[Prognostic significance of minimal residual disease before post-remission therapy in younger adult acute myeloid leukemia patients with intermediate risk and negative of FLT3-ITD, NPM1 and biallelic CEBPA mutations].

作者：Yaping Zhang, Yifei Zhang, Yuqing Zhang, Guilin Tang, W P Zhang, Jin Yang, J M Wang, Xiaoxia Hu · 发表于：PubMed · 年份：2019 · DOI：10.3760/cma.j.issn.0253-2727.2019.07.012 · 被引用次数：1 · 研究领域：Acute Myeloid Leukemia Research、Myeloproliferative Neoplasms: Diagnosis and Treatment、Retinoids in leukemia and cellular processes